Lost in translation: assessing the nomenclature change for diabetic kidney disease in Japan (original) (raw)

• Japanese Society of Nephrology. Evidence-based CKD Clinical Practice Guidelines 2018, Tokyo: Tokyo-igakusha; 2018
• The 64th Annual Meeting of the Japanese Society of Nephrology. http://jsn64.umin.jp/
• The 64th Annual Meeting of the Japan Diabetes Society. https://site.convention.co.jp/64jds/
• The American Diabetes Association 81st Scientific Sessions. https://ada.scientificposters.com/epsSearchADA.cfm
• Kidney Week 2021 of the American Society of Nephrology. https://www.asn-online.org/education/kidneyweek/2021/program-annual.aspx?day=Thursday
• Friedman EA. Diabetic nephropathy: strategies in prevention and management. Kidney Int. 1982;21:780–91.
  Article CAS PubMed Google Scholar
• Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(Suppl. 2):64–78.
  Article PubMed Google Scholar
• Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987;31:673–89.
  Article CAS PubMed Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1–150.
  Google Scholar
• Haneda M, Utsunomiya K, Koya D, et al. A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy. Diabetol Int. 2014;5:207–11.
  Article Google Scholar
• Zins EI. Diabetic nephropathy. Am J Med Sci. 1949;218:408–18.
  Article CAS PubMed Google Scholar
• Wilson JL, Root HF, Marble A. Diabetic nephropathy; a clinical syndrome. N Engl J Med. 1951;245:513–7.
  Article CAS PubMed Google Scholar
• Goetz FC, Kjellstrand CM. The treatment of diabetic kidney disease. Diabetologia. 1979;17:267–81.
  Article CAS PubMed Google Scholar
• Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med. 1984;310:356–60.
  Article CAS PubMed Google Scholar
• Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diabetes Metab Rev. 1988;5:453–83.
  Article Google Scholar
• KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49 (2):S1-S182
• Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014;64:510–33.
  Article PubMed Google Scholar
• Diabetes Canada Clinical Practice Guidelines Expert Committee, McFarlane P, Cherney D, et al. Chronic kidney disease in diabetes. Can J Diabetes. 2018; 42(1): S201-S209
• Liew A, Bavanandan S, Prasad N, et al. Asian Pacific society of nephrology clinical practice guideline on diabetic kidney disease. Nephrology. 2020;25(Suppl. 2):S12–45.
  Article Google Scholar
• Fioretto P, Mauer M. Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27:195–207.
  Article PubMed PubMed Central Google Scholar
• Cohen Tervaert TW, Mooyaart AL, Amann K, et al. Pathological classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556–63.
  Article Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2020;98(4S):S1-S115
• Hur KY, Moon MK, Park JS, et al. 2021 Clinical practice guidelines for diabetes mellitus of the Korean diabetes association. Diabetes Metab J. 2021;45:461–81.
  Article PubMed PubMed Central Google Scholar
• National Institute for Health and Care Excellence (NICE). Chronic kidney disease: assessment and management: 2021. https://www.nice.org.uk/guidance/ng203/resources/chronic-kidney-disease-assessment-and-management-pdf-66143713055173
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl. 1):S1–266.
  Google Scholar
• Levey AS, Eckardt K-U, Dorman NM, et al. Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference. Kidney Int. 2020;97:1117–29.
  Article PubMed Google Scholar
• Anders H-J, Huber TB, Isermann B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361–77.
  Article CAS PubMed Google Scholar
• Alicic RZ, Johnson EJ, Tuttle KR. Diabetic kidney disease. In: Himmelfarb J, Ikizler TA, editors. Chronic kidney disease, dialysis, and transplantation. 4th ed. Philadelphia: Elsevier; 2019. p. 42–61.
  Chapter Google Scholar
• Fornoni A, Nelson RG, Najafian B, Groop PH. Epidemiology of diabetic kidney disease. In: Yu ASL, Chertow GM, Luyckx V, Marsden PA, Skorecki K, Taal MW, editors. Brenner and rector’s the kidney. 11th ed. Elsevier; 2019. p. 1327–79.
  Google Scholar
• Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl. 2018;8:2–7.
  Article Google Scholar
• Yokoyama H, Araki S, Kawai K, et al. The prognosis of patients with type 2 diabetes and nonalbuminuric diabetic kidney disease is not always poor: implication of the effects of coexisting macrovascular complications (JDDM 54). Diabetes Care. 2020;43:1102–10.
  Article CAS PubMed Google Scholar
• Afkarian M, Zelnick LR, Hall YN, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988–2014. JAMA. 2016;316:602–10.
  Article PubMed PubMed Central Google Scholar
• Tanaka N, Yamamoto Y, Yokoyama Y, et al. Temporal trends in the prevalence of albuminuria and reduced eGFR in Japanese patients with type 2 diabetes. Diabetol Int. 2019;10:279–87.
  Article PubMed PubMed Central Google Scholar
• Kume S, Araki SI, Ugi S, et al. Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014. J Diabetes Investig. 2019;10:1032–40.
  Article CAS PubMed PubMed Central Google Scholar
• Shiraishi N, Kitamura K, Kohda Y, et al. Prevalence and risk factor analysis of nephrosclerosis and ischemic nephropathy in the Japanese general population. Clin Exp Nephrol. 2014;18:461–8.
  Article CAS PubMed Google Scholar
• Glassock RJ, Delanaye P, Rule AD. Should the definition of CKD be changed to include age-adapted GFR criteria? YES Kidney Int. 2020;97:34–7.
  Article PubMed Google Scholar
• Levey A, Inker LA, Coresh J. “Should the definition of CKD be changed to include age-adapted GFR criteria?” Con: the evaluation and management of CKD, not the definition, should be age-adapted. Kidney Int. 2020;97:37–40.
  Article PubMed Google Scholar
• Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152:561–7.
  Article PubMed PubMed Central Google Scholar
• Masakane I, Nakai S, Ogata S, et al. An overview of regular dialysis treatment in Japan (As of 31 December 2013). Ther Apher Dial. 2015;19:540–74.
  Article CAS PubMed Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(suppl 1):6–7.
  Article Google Scholar
• Abe M, Okada K, Maruyama N, et al. Comparison of clinical trajectories before initiation of renal replacement therapy between diabetic nephropathy and nephrosclerosis on the KDIGO Guidelines Heat Map. J Diabetes Res 2016;5374746
• Anderson S, Rennke H, Brenner B. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993–2000.
  Article CAS PubMed PubMed Central Google Scholar
• Araki S, Haneda M, Sugimoto T, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–1987.
  Article CAS PubMed Google Scholar
• Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380:2295–306.
  Article CAS PubMed Google Scholar
• Koye DN, Magliano DJ, Reid CM, et al. Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis. 2018;72:653–66.
  Article PubMed Google Scholar
• Yoshida Y, Kashiwabara K, Hirakawa Y, et al. Conditions, pathogenesis, and progression of diabetic kidney disease and early decliner in Japan. BMJ Open Diab Res Care. 2020;8: e000902.
  Article PubMed PubMed Central Google Scholar
• Yamanouchi M, Furuichi K, Hoshino J, et al. Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score-matched analysis of a nationwide, biopsy-based cohort study. Diabetes Care. 2019;42:891–902.
  Article CAS PubMed Google Scholar
• Yamamoto Y, Hanai K, Mori T, et al. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency. Diabetologia. 2022;65:234–45.
  Article CAS PubMed Google Scholar